The Schall Law Firm Encourages Shareholder Involvement in Securities Fraud Lawsuit Against Kyverna Therapeutics Inc.
The Schall Law Firm Files Class Action Lawsuit Against Kyverna Therapeutics, Inc. December 18, 2024 The Schall Law Firm, a national shareholder rights litigation firm, has announced the filing of a class action lawsuit against Kyverna Therapeutics, Inc. (“Kyverna” or “the Company”) (NASDAQ:KYTX) for violations of the federal securities laws. Investors who purchased the Company’s…